Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT.
暂无分享，去创建一个
B. Condon | Yong Wang | S. Geeganage | T. Raub | D. Johns | T. Burkholder | J. Clayton | M. Rempala | O. de Frutos | Carlos Mateos | S. Stout | W. Ehlhardt | Z. Lu | K. Henry | Sheela Ashok | S. Parthasarathy | H. Pei | Pablo D. Garcia | Sehila Pleite | Mei Lai | T. P. Burkholder